Immuron Ltd Files 6-K Reporting January Announcements

Ticker: IMRN · Form: 6-K · Filed: Jan 17, 2025 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateJan 17, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing, 6-K, announcement

Related Tickers: IMRN

TL;DR

IMMURON LTD (IMRN) FILED A 6-K ON JAN 17, 2025, REPORTING ON THREE JANUARY ANNOUNCEMENTS. NO 12G3-2(B) INFO FURNISHED.

AI Summary

On January 17, 2025, Immuron Limited filed a Form 6-K, reporting on three announcements made during January 2025. The filing indicates that Immuron is a foreign private issuer and is not furnishing information under Rule 12g3-2(b). The company is incorporated in Australia and its fiscal year ends on June 30.

Why It Matters

This filing provides an update on Immuron Limited's recent communications to the market, which may contain information relevant to investors regarding the company's operations and strategic developments.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer announcements and does not contain significant new financial or operational information that would immediately alter risk perception.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K filing is to report on three announcements published by Immuron Limited during the month of January 2025.

Is Immuron Limited furnishing information under Rule 12g3-2(b)?

No, the filing explicitly indicates 'No' for furnishing information under Rule 12g3-2(b).

What is Immuron Limited's principal executive office address?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

What is Immuron Limited's fiscal year end?

Immuron Limited's fiscal year ends on June 30.

What is Immuron Limited's SEC file number?

Immuron Limited's SEC file number is 001-38104.

Filing Stats: 338 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-01-17 08:00:02

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published three announcements (the “Public Notices”) to the Australian Securities Exchange on January 17, 2025 titled: - “Immuron Travelan continued strong sales growth” - “Application for quotation of securities - IMC” - “Notice under section 708A” A copy of the Public Notices are attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron Travelan continued strong sales growth 99.2 Application for quotation of securities - IMC 99.3 Notice under section 708A 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: January 17, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing